Parkinson’s disease psychosis
نویسندگان
چکیده
License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php Journal of Parkinsonism and Restless Legs Syndrome 2014:4 41–51 Journal of Parkinsonism and Restless Legs Syndrome Dovepress
منابع مشابه
Risk Factors for Psychosis in Parkinson’s Disease
P sychosis is a characteristic neuropsychiatric symptom of Parkinson’s disease (PD) that is common and associated with worse outcomes. The purpose of this article is to review identified risk factors for visual hallucinations in PD, the most common manifestation of psychosis. With the possible exception of dopamine agonists, antiparkinsonian medications are only considered modifiers of psychosi...
متن کاملQuetiapine for hypersexuality and delusional jealousy after stroke.
To the Editors: Hypersexuality and psychotic symptoms are occasionally associated with Parkinson’s disease, dopamine agonist therapy for Parkinson’s disease, dementia, and temporal lobe seizures, but rarely with stroke. Although some studies have shown that quetiapine is effective in treating psychosis and motor functions in Parkinson’s disease, as far as we know, there have not been any treatm...
متن کاملPsychotic Symptoms in Parkinson’s Disease
Psychosis is generally defined as a mental condition where there is a significant derangement in the perception of reality. Specific features of psychosis include hallucinations, delusions, disorganized speech (related to disorganized thinking) and bizarre behavior (based on the disorganized thinking). In Parkinson’s disease the most common source of psychotic symptoms is related to treatment w...
متن کاملA New Perspective in the Treatment of Parkinson’s Disease Psychosis
N europsychiatric symptoms, such as psychosis, are well described in Parkinson’s disease (PD); most appear to be due to disease pathology with exacerbation caused by dopaminergic treatment. More than 50% of patients with PD develop psychosis at some point throughout their disease course. Clinicians need to routinely assess patients with PD for psychotic symptoms, particularly hallucinations. Tr...
متن کاملTherapies under investigation for treating Parkinson’s disease psychosis
2014 Parkinson’s disease (PD) psychosis is a distressing condition that affects up to 60% of patients at the advanced stages of the disease. It significantly impairs patients’ and caregiver’s quality of life. Current therapeutic options are limited, and only clozapine and, more recently, pimavanserin were demonstrated to be effective in Phase III clinical trials. Phase II studies, open-label tr...
متن کاملPimavanserin for psychosis in patients with Parkinson’s disease
Pimavanserin is a potent 5-HT2A inverse agonist and 5-HT2C inverse agonist, with 5-fold greater affinity for the 5-HT2A receptor.1 Although antagonists block agonist actions at the receptor site, inverse agonists reduce the level of baseline constitutive activity seen in many G protein-coupled receptors. This medication is FDA approved for treating hallucinations and delusions associated with P...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2014